HUP0002643A2 - Szívrendellenességek kezelése és megelőzése SSRI-k alkalmazásával - Google Patents
Szívrendellenességek kezelése és megelőzése SSRI-k alkalmazásávalInfo
- Publication number
- HUP0002643A2 HUP0002643A2 HU0002643A HUP0002643A HUP0002643A2 HU P0002643 A2 HUP0002643 A2 HU P0002643A2 HU 0002643 A HU0002643 A HU 0002643A HU P0002643 A HUP0002643 A HU P0002643A HU P0002643 A2 HUP0002643 A2 HU P0002643A2
- Authority
- HU
- Hungary
- Prior art keywords
- ssri
- prevention
- treatment
- disorders
- selective serotonin
- Prior art date
Links
- 208000019622 heart disease Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 208000020446 Cardiac disease Diseases 0.000 title 1
- 230000000697 serotonin reuptake Effects 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000007536 Thrombosis Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000010125 myocardial infarction Diseases 0.000 abstract 2
- 230000008506 pathogenesis Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 abstract 2
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 abstract 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 229960001653 citalopram Drugs 0.000 abstract 1
- 229960002464 fluoxetine Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
A találmány tárgya eljárás szívrendellenességek, például a trombózispatogenezisével kapcsolatos rendellenességek, így a szívizominfarktuskezelésére és/vagy megelőzésére emberekben vagy állatokban, amelyneksorán egy arra rászoruló embernek vagy állatnak beadják egyszerotonin-újrafelvétel szelektív inhibitornak (SSRI-nek) - példáulparoxetin, fluoxetin, citalopram vagy fluoroxamin - vagygyógyászatilag elfogadható sójának hatásos, nem toxikus mennyiségét. Atalálmány tárgyát képezi ezenkívül egy SSRI-nek vagy gyógyá- szatilagelfogadható sójának az alkalmazása szívrendellenességek, például atrombózis patogenezisével kapcsolatos rendellenességek, így aszívizominfarktus kezelésére és/vagy megelőzésére szolgálógyógyszerkészítmények előállítására. A találmány kiterjed az ígyelőállított gyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714841.5A GB9714841D0 (en) | 1997-07-14 | 1997-07-14 | Treatment method |
| PCT/GB1998/002073 WO1999003469A1 (en) | 1997-07-14 | 1998-07-14 | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0002643A2 true HUP0002643A2 (hu) | 2001-10-28 |
| HUP0002643A3 HUP0002643A3 (en) | 2001-11-28 |
Family
ID=10815849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002643A HUP0002643A3 (en) | 1997-07-14 | 1998-07-14 | Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6372763B1 (hu) |
| EP (1) | EP0996445A1 (hu) |
| JP (1) | JP2001510155A (hu) |
| KR (1) | KR20010021796A (hu) |
| CN (1) | CN1263465A (hu) |
| AU (1) | AU739466B2 (hu) |
| BR (1) | BR9811004A (hu) |
| CA (1) | CA2296468A1 (hu) |
| GB (1) | GB9714841D0 (hu) |
| HU (1) | HUP0002643A3 (hu) |
| IL (1) | IL133908A0 (hu) |
| NO (1) | NO20000169L (hu) |
| NZ (1) | NZ502201A (hu) |
| PL (1) | PL337996A1 (hu) |
| TR (1) | TR200000090T2 (hu) |
| WO (1) | WO1999003469A1 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245782B1 (en) * | 1999-05-17 | 2001-06-12 | Heartdrug Research L.L.C. | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IS6021A (is) * | 2000-08-10 | 2001-10-20 | H. Lundbeck A/S | Lyfjasamsetningar sem innihalda sítalópram |
| TR200400189T2 (tr) | 2001-07-31 | 2004-12-21 | H.Lundbeck A/S | Esitalopram içeren kristal yapılı bileşim. |
| US20040220153A1 (en) * | 2002-09-24 | 2004-11-04 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| WO2004058354A1 (en) * | 2002-12-20 | 2004-07-15 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT768083E (pt) * | 1995-07-17 | 2003-08-29 | Pfizer | Sertralina para o tratamento de doentes pos-enfarte miocardico |
-
1997
- 1997-07-14 GB GBGB9714841.5A patent/GB9714841D0/en active Pending
-
1998
- 1998-07-14 JP JP2000502768A patent/JP2001510155A/ja active Pending
- 1998-07-14 CN CN98807172A patent/CN1263465A/zh active Pending
- 1998-07-14 AU AU83494/98A patent/AU739466B2/en not_active Ceased
- 1998-07-14 IL IL13390898A patent/IL133908A0/xx unknown
- 1998-07-14 EP EP98933796A patent/EP0996445A1/en not_active Withdrawn
- 1998-07-14 PL PL98337996A patent/PL337996A1/xx unknown
- 1998-07-14 HU HU0002643A patent/HUP0002643A3/hu unknown
- 1998-07-14 NZ NZ502201A patent/NZ502201A/en unknown
- 1998-07-14 KR KR1020007000360A patent/KR20010021796A/ko not_active Application Discontinuation
- 1998-07-14 TR TR2000/00090T patent/TR200000090T2/xx unknown
- 1998-07-14 BR BR9811004-7A patent/BR9811004A/pt not_active Application Discontinuation
- 1998-07-14 US US09/462,854 patent/US6372763B1/en not_active Expired - Fee Related
- 1998-07-14 CA CA002296468A patent/CA2296468A1/en not_active Abandoned
- 1998-07-14 WO PCT/GB1998/002073 patent/WO1999003469A1/en not_active Application Discontinuation
-
2000
- 2000-01-13 NO NO20000169A patent/NO20000169L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL337996A1 (en) | 2000-09-25 |
| AU8349498A (en) | 1999-02-10 |
| EP0996445A1 (en) | 2000-05-03 |
| NO20000169D0 (no) | 2000-01-13 |
| GB9714841D0 (en) | 1997-09-17 |
| IL133908A0 (en) | 2001-04-30 |
| NO20000169L (no) | 2000-01-13 |
| JP2001510155A (ja) | 2001-07-31 |
| CN1263465A (zh) | 2000-08-16 |
| HUP0002643A3 (en) | 2001-11-28 |
| BR9811004A (pt) | 2000-09-19 |
| AU739466B2 (en) | 2001-10-11 |
| US6372763B1 (en) | 2002-04-16 |
| TR200000090T2 (tr) | 2000-09-21 |
| KR20010021796A (ko) | 2001-03-15 |
| NZ502201A (en) | 2001-12-21 |
| WO1999003469A1 (en) | 1999-01-28 |
| CA2296468A1 (en) | 1999-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
| KR980000447A (ko) | 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물 | |
| DE69634609D1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu-opioidanagonisten und eines kappa - 2- opioidanagonisten | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200501496A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| ATE319474T1 (de) | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| DK0910647T3 (da) | Human DNase i hyperaktive varianter | |
| SE9503924D0 (sv) | Novel opioid peptides | |
| PA8603201A1 (es) | Procedimiento y composiciones farmaceuticas para el tratamiento de arterosclerosis, dislipidemias y afecciones relacionadas | |
| HUP0300099A2 (en) | Vaccine for the treatment of artherosclerosis | |
| SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
| NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
| ATE265851T1 (de) | Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden | |
| HUP0002643A2 (hu) | Szívrendellenességek kezelése és megelőzése SSRI-k alkalmazásával | |
| PT100415A (pt) | Novas morfolinas de accao farmaceutica, e processo para a sua preparacao | |
| NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
| DE69626916D1 (de) | Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| NO20024683L (no) | Terapier med oppdelte doser som har vaskulirt skadende aktivitet | |
| MY131159A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
| PT1183046E (pt) | Derivado de aminotetralina para a terapia de doencas cardiovasculares |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |